Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Protalix BioTherapeutics (PLX) Pension (2016 - 2025)

Protalix BioTherapeutics (PLX) has 16 years of Pension data on record, last reported at $631000.0 in Q3 2025.

  • For Q3 2025, Pension fell 13.56% year-over-year to $631000.0; the TTM value through Sep 2025 reached $631000.0, down 13.56%, while the annual FY2024 figure was $559000.0, 21.71% down from the prior year.
  • Pension reached $631000.0 in Q3 2025 per PLX's latest filing, up from $615000.0 in the prior quarter.
  • Across five years, Pension topped out at $2.5 million in Q1 2022 and bottomed at $551000.0 in Q1 2025.
  • Average Pension over 5 years is $1.4 million, with a median of $1.6 million recorded in 2023.
  • Peak YoY movement for Pension: grew 12.69% in 2021, then tumbled 56.52% in 2023.
  • A 5-year view of Pension shows it stood at $2.5 million in 2021, then tumbled by 33.58% to $1.6 million in 2022, then plummeted by 56.52% to $714000.0 in 2023, then dropped by 21.71% to $559000.0 in 2024, then increased by 12.88% to $631000.0 in 2025.
  • Per Business Quant database, its latest 3 readings for Pension were $631000.0 in Q3 2025, $615000.0 in Q2 2025, and $551000.0 in Q1 2025.